SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-085791
Filing Date
2023-11-13
Accepted
2023-11-13 12:10:27
Documents
79
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_intensity.htm   iXBRL 10-Q 762412
2 CERTIFICATION f10q0923ex31-1_intensity.htm EX-31.1 16665
3 CERTIFICATION f10q0923ex31-2_intensity.htm EX-31.2 16711
4 CERTIFICATION f10q0923ex32-1_intensity.htm EX-32.1 6603
5 CERTIFICATION f10q0923ex32-2_intensity.htm EX-32.2 6647
11 GRAPHIC image_001.jpg GRAPHIC 26431
  Complete submission text file 0001213900-23-085791.txt   4889687

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ints-20230930.xsd EX-101.SCH 60748
7 XBRL CALCULATION FILE ints-20230930_cal.xml EX-101.CAL 29675
8 XBRL DEFINITION FILE ints-20230930_def.xml EX-101.DEF 266270
9 XBRL LABEL FILE ints-20230930_lab.xml EX-101.LAB 471801
10 XBRL PRESENTATION FILE ints-20230930_pre.xml EX-101.PRE 275925
73 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_intensity_htm.xml XML 487977
Mailing Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880
Business Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

IRS No.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41109 | Film No.: 231396897
SIC: 2836 Biological Products, (No Diagnostic Substances)